https://preview.xbpnews.com/zscaler-inc-zs-rating-downgrade-in-line-outlook-from-evercore-isi Stocks Telegraph en 2026-05-27 Zscaler, Inc. (ZS) Rating Downgrade: In-Line Outlook from Evercore ISI https://preview.xbpnews.com/verra-mobility-corporation-vrrm-downgraded-to-underweight-by-jp-morgan-price-target-set-at-8 Stocks Telegraph en 2026-05-27 Verra Mobility Corporation (VRRM): Downgraded to Underweight by JP Morgan; Price Target Set at $8 https://preview.xbpnews.com/kosmos-energy-ltd-kos-receives-underperform-rating-analyzing-analysts-outlook-and-recent-market-activity Stocks Telegraph en 2026-05-27 Kosmos Energy Ltd. (KOS) Receives Underperform Rating: Analyzing Analysts’ Outlook and Recent Market Activity https://preview.xbpnews.com/first-interstate-bancsystem-inc-fibk-receives-neutral-rating-from-da-davidson-what-it-means-for-investors Stocks Telegraph en 2026-05-27 First Interstate BancSystem, Inc. (FIBK) Receives Neutral Rating from DA Davidson: What It Means for Investors https://preview.xbpnews.com/hf-sinclair-corporation-dino-receives-neutral-rating-from-mizuho-price-target-suggests-upside-potential Stocks Telegraph en 2026-05-27 HF Sinclair Corporation (DINO) Receives Neutral Rating from Mizuho; Price Target Suggests Upside Potential https://preview.xbpnews.com/acnb-corporation-acnb-steady-performance-under-new-market-rating Stocks Telegraph en 2026-05-27 ACNB Corporation (ACNB): Steady Performance Under New Market Rating https://preview.xbpnews.com/3-stocks-that-could-shift-higher-mira-pharmaceuticals-mira-concord-medical-services-ccm-cardiol-therapeutics-crdl Stocks Telegraph en 2026-05-27 3 Stocks That Could Shift Higher: Mira Pharmaceuticals (MIRA), Concord Medical Services (CCM), Cardiol Therapeutics (CRDL) https://preview.xbpnews.com/3-stocks-on-the-move-lunai-bioworks-lnai-cardiol-therapeutics-crdl-aspire-biopharma-asbp Stocks Telegraph en 2026-05-27 3 Stocks on the Move: Lunai Bioworks (LNAI), Cardiol Therapeutics (CRDL), Aspire Biopharma (ASBP) https://preview.xbpnews.com/3-stocks-showing-market-activity-cardiol-therapeutics-crdl-boundless-bio-bold-nextcure-nxtc Stocks Telegraph en 2026-05-27 3 Stocks Showing Market Activity: Cardiol Therapeutics (CRDL), Boundless Bio (BOLD), Nextcure (NXTC) https://preview.xbpnews.com/the-travelers-companies-inc-trv-neutral-rating-from-jp-morgan-with-potential-upside Stocks Telegraph en 2026-05-26 The Travelers Companies, Inc. (TRV): Neutral Rating from JP Morgan with Potential Upside https://preview.xbpnews.com/the-timken-company-tkr-receives-overweight-rating-from-jp-morgan-target-price-at-150 Stocks Telegraph en 2026-05-26 The Timken Company (TKR) Receives Overweight Rating from JP Morgan, Target Price at $150 https://preview.xbpnews.com/tectonic-therapeutic-inc-tecx-strong-buy-rating-indicates-significant-upside-potential Stocks Telegraph en 2026-05-26 Tectonic Therapeutic, Inc. (TECX): Strong Buy Rating Indicates Significant Upside Potential https://preview.xbpnews.com/occidental-petroleum-corporation-oxy-barclays-upgrades-to-overweight-with-price-target-of-72 Stocks Telegraph en 2026-05-26 Occidental Petroleum Corporation (OXY): Barclays Upgrades to Overweight with Price Target of $72 https://preview.xbpnews.com/marvell-technology-inc-mrvl-receives-buy-rating-from-hsbc-price-target-of-300 Stocks Telegraph en 2026-05-26 Marvell Technology, Inc. (MRVL) Receives ‘Buy’ Rating from HSBC, Price Target of $300 https://preview.xbpnews.com/cognex-corporation-cgnx-receives-overweight-rating-from-jp-morgan-with-price-target-of-75 Stocks Telegraph en 2026-05-26 Cognex Corporation (CGNX) Receives Overweight Rating from JP Morgan with Price Target of $75 https://preview.xbpnews.com/booz-allen-hamilton-holding-corporation-bah-analyst-rating-upgraded-to-buy-with-significant-upside-potential Stocks Telegraph en 2026-05-26 Booz Allen Hamilton Holding Corporation (BAH): Analyst Rating Upgraded to Buy with Significant Upside Potential https://preview.xbpnews.com/astrana-health-inc-asth-upgraded-to-overweight-strong-upside-potential-ahead Stocks Telegraph en 2026-05-26 Astrana Health, Inc. (ASTH) Upgraded to Overweight: Strong Upside Potential Ahead https://preview.xbpnews.com/allient-inc-alnt-upgrade-to-overweight-signals-optimism-price-target-set-at-80 Stocks Telegraph en 2026-05-26 Allient Inc. (ALNT) Upgrade to Overweight Signals Optimism; Price Target Set at $80 https://preview.xbpnews.com/agilon-health-inc-agl-barclays-analysts-shift-to-equal-weight-elevating-price-target-to-81 Stocks Telegraph en 2026-05-26 Agilon Health, Inc. (AGL): Barclays Analysts Shift to Equal-Weight, Elevating Price Target to $81 https://preview.xbpnews.com/lear-corporation-lea-td-cowen-upgrades-to-buy-with-target-price-of-165 Stocks Telegraph en 2026-05-26 Lear Corporation (LEA): TD Cowen Upgrades to Buy with Target Price of $165 https://preview.xbpnews.com/cosan-s-a-csan-downgraded-to-reduce-price-target-set-at-3-20 Stocks Telegraph en 2026-05-26 Cosan S.A. (CSAN) Downgraded to Reduce: Price Target Set at $3.20 https://preview.xbpnews.com/baycom-corp-bcml-secures-neutral-rating-with-analyst-price-target-indicating-upside-potential Stocks Telegraph en 2026-05-26 BayCom Corp (BCML) Secures Neutral Rating with Analyst Price Target Indicating Upside Potential https://preview.xbpnews.com/3-stocks-showing-consistent-activity-xbiotech-xbit-cue-biopharma-cue-cardiol-therapeutics-crdl Stocks Telegraph en 2026-05-26 3 Stocks Showing Consistent Activity: XBiotech (XBIT), Cue Biopharma (CUE), Cardiol Therapeutics (CRDL) https://preview.xbpnews.com/3-stocks-that-could-attract-attention-burning-rock-biotech-bnr-cardiol-therapeutics-crdl-dbv-technologies-dbvt Stocks Telegraph en 2026-05-26 3 Stocks That Could Attract Attention: Burning Rock Biotech (BNR), Cardiol Therapeutics (CRDL), DBV Technologies (DBVT) https://preview.xbpnews.com/3-stocks-that-could-gain-ground-cardiol-therapeutics-crdl-adlai-nortye-anl-neurogene-ngne Stocks Telegraph en 2026-05-26 3 Stocks That Could Gain Ground: Cardiol Therapeutics (CRDL), Adlai Nortye (ANL), Neurogene (NGNE)